GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: Fareston® | Farestone® | FC-1157a
                                 
                                                         
                            
                            
                            
                                 
                                
                                toremifene is an approved drug (EMA (1996), FDA (1997)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Toremifene is an orally active, selective estrogen receptor modulator (SERM).
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Price N, Sartor O, Hutson T, Mariani S. (2005)
                                         Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer. Clin Prostate Cancer, 3 (4): 211-4. [PMID:15882476]  |